In particular, genetic variables, such as GBA mutation (Chung et al., 2021) or specific nucleotide polymorphisms (Greenbaum et al., 2013), have been suggested to be responsible for preserved motor performances in PD patients in spite of nigrostriatal dopamine depletion. This evidence concerns the gene GBA1 and Parkinson disease.